195 results
Page 3 of 10
6-K
i93zbwg42lt2sb2ye
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
zle 40k8byn8
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
f71 i8remti
30 Nov 22
Current report (foreign)
6:28am
6-K
kc9eo
4 Nov 22
Current report (foreign)
6:01am
6-K
EX-99.1
xa3z074rw b6d12g
27 Oct 22
Current report (foreign)
6:01am
6-K
dgreq2gxllr
14 Oct 22
Current report (foreign)
7:36am
6-K
e06luwvd
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
39b s3d7mdf9bfup
23 Aug 22
Current report (foreign)
6:13am
6-K
EX-99.1
gvsgewg ktnxdavkyfk
4 Aug 22
Current report (foreign)
6:07am
6-K
u7baaj85 50n2f19
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
uy2odshylgthw5 3i
28 Jul 22
Current report (foreign)
6:09am
6-K
462loan
11 Jul 22
Current report (foreign)
6:05am
6-K
rkjcmrm19 3t
29 Jun 22
Current report (foreign)
6:02am
6-K
rz0kfqwnry82bed7 h4q
31 May 22
Current report (foreign)
6:20am
6-K
3vvrlp0oh7
31 May 22
Current report (foreign)
6:18am
6-K
EX-99.1
596spzo57pv kk6qqzxr
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
bvm801bu wnshb8
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
vhycgym
31 May 22
Current report (foreign)
12:00am
6-K
n03yx
11 May 22
Current report (foreign)
6:11am